{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:43:12Z","timestamp":1791405792435,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jim.2025.113812","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T22:37:05Z","timestamp":1737931025000},"page":"113812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The Fas-mediated apoptosis assay: From concept to clinical application"],"prefix":"10.1016","volume":"537","author":[{"given":"Jack","family":"Bleesing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2025.113812_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.immunol.24.021605.090513","article-title":"Genetic disorders of programmed cell death in the immune system","volume":"24","author":"Bidere","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.jim.2025.113812_bb0010","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood.V98.8.2466","article-title":"Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome","volume":"98","author":"Bleesing","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jim.2025.113812_bb0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajhg.2010.10.028","article-title":"Whole-exome-sequencing-based discovery of human FADD deficiency","volume":"87","author":"Bolze","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.jim.2025.113812_bb0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.jim.2025.113812_bb0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jim.2025.113812_bb0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jim.2025.113812_bb0035","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10875-020-00779-6","article-title":"Novel compound heterozygote variations in FADD identified to cause Fas-associated protein with death domain deficiency","volume":"40","author":"Kohn","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.jim.2025.113812_bb0040","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2014-01-548958","article-title":"RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia","volume":"123","author":"Lanzarotti","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jim.2025.113812_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10875-012-9811-z","article-title":"A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis","volume":"33","author":"Lo","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jim.2025.113812_bb0050","first-page":"388","article-title":"The genetic landscape of the FAS pathway deficiencies","volume":"44","author":"Magerus","year":"2021","journal-title":"Biom. J."},{"issue":"2","key":"10.1016\/j.jim.2025.113812_bb0055","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","volume":"131","author":"Magerus-Chatinet","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2025.113812_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2014.10.006","article-title":"A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome","volume":"155","author":"Nabhani","year":"2014","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jim.2025.113812_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.jim.2025.113812_bb0070","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis","volume":"117","author":"Niemela","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.jim.2025.113812_bb0075","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1073\/pnas.0702975104","article-title":"NRAS mutation causes a human autoimmune lymphoproliferative syndrome","volume":"104","author":"Oliveira","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jim.2025.113812_bb0080","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4326","article-title":"Restimulation-induced cell death (RICD): methods for modeling, investigating, and quantifying RICD sensitivity in primary human T cells via flow cytometric analysis","volume":"12","author":"Pohida","year":"2022","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.jim.2025.113812_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coi.2017.10.001","article-title":"What\u2019s up in the ALPS","volume":"49","author":"Rieux-Laucat","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.jim.2025.113812_bb0090","first-page":"422","article-title":"RASopathies: from germline mutations to somatic and multigenic diseases","volume":"44","author":"Riller","year":"2021","journal-title":"Biom. J."},{"issue":"6","key":"10.1016\/j.jim.2025.113812_bb0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/pr.2015.170","article-title":"Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation","volume":"78","author":"Ruiz-Garcia","year":"2015","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.jim.2025.113812_bb0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2015.02.002","article-title":"A new case of Fas-associated death domain protein deficiency and update on treatment outcomes","volume":"136","author":"Savic","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113812_bb0105","article-title":"Apoptosis signaling pathways","author":"Siegel","year":"2002","journal-title":"Curr. Protoc. Immunol."},{"issue":"10","key":"10.1016\/j.jim.2025.113812_bb0110","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency","volume":"119","author":"Snow","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2025.113812_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-065X.2010.00917.x","article-title":"The power and the promise of restimulation-induced cell death in human immune diseases","volume":"236","author":"Snow","year":"2010","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.jim.2025.113812_bb0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2015.08.025","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly","volume":"137","author":"Sobh","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.jim.2025.113812_bb0125","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation","volume":"117","author":"Takagi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jim.2025.113812_bb0130","first-page":"9","article-title":"The essentials of developmental apoptosis","author":"Voss","year":"2020","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.jim.2025.113812_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jim.2025.113812_bb0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/imr.12535","article-title":"Restimulation-induced cell death: new medical and research perspectives","volume":"277","author":"Zheng","year":"2017","journal-title":"Immunol. Rev."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:12:38Z","timestamp":1740071558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175925000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"alternative-id":["S0022175925000122"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2025.113812","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Fas-mediated apoptosis assay: From concept to clinical application","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2025.113812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113812"}}